Submitted by Anonymous (not verified) on 10 June 2025 - 15:38
Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastrointestinal disorders, PIP number: P/0129/2024
Source:
